Proteolytic enhancement of rotavirus infectivity: biology mechanism.
D000818:Animals; D001769:Blood; D002460:Cell Line; D002918:Chymotrypsin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D000882:Haplorhini; D010196:Pancreatic Elastase / Q000494:pharmacology*; D010194:Pancreatin / Q000494:pharmacology; D012328:RNA Viruses / Q000254:growth & development*; D011817:Rabbits; D012401:Rotavirus / Q000187:drug effects / Q000254:growth & development*; D013997:Time Factors; D014357:Trypsin / Q000494:pharmacology*; D014361:Trypsin Inhibitors / Q000494:pharmacology
D014361:Trypsin Inhibitors; D010194:Pancreatin; D002918:Chymotrypsin; D010196:Pancreatic Elastase; D014357:Trypsin